Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Ruschitzka

Showing results (1-10 of 522) with videos related to

Pageof 53
Sort By:
Journal of Hypertension|December 14, 2011
Evidence for improvement in survival with antihypertensive combination treatmentFrank Ruschitzka
Heart Rhythm|April 24, 2012
The challenge of nonresponders to cardiac resynchronization therapy: lessons learned from oncologyFrank Ruschitzka
Current Hypertension Reports|March 17, 2007
Painful lessons: COX-2 inhibitors, NSAIDs, and hypertensionFrank Ruschitzka
Nature Clinical Practice. Cardiovascular Medicine|September 28, 2005
Are selective cyclo-oxygenase 2 inhibitors safe after coronary artery bypass grafting surgery?Frank Ruschitzka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2006
Novel anti-inflammatory drugs in hypertensionMatthias Hermann, Frank Ruschitzka
International Journal of Clinical Practice|January 18, 2006
'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?Henry Krum, Frank Ruschitzka
Annals of Medicine|March 17, 2007
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugsMatthias Hermann, Frank Ruschitzka
Current Hypertension Reports|November 4, 2010
Is there a link between angiotensin receptor blockers and cancer?Frank Enseleit, Frank Ruschitzka
European Heart Journal|March 11, 2011
Beyond dyspnoea as an endpoint in acute heart failure trialsMihai Gheorghiade, Frank Ruschitzka
Current Hypertension Reports|March 28, 2008
Vitamin D and hypertensionMatthias Hermann, Frank Ruschitzka
Pageof 53

Showing results (1-10 of 522) with videos related to

Sort By:
Pageof 53
Journal of Hypertension|December 14, 2011
Evidence for improvement in survival with antihypertensive combination treatmentFrank Ruschitzka
Heart Rhythm|April 24, 2012
The challenge of nonresponders to cardiac resynchronization therapy: lessons learned from oncologyFrank Ruschitzka
Current Hypertension Reports|March 17, 2007
Painful lessons: COX-2 inhibitors, NSAIDs, and hypertensionFrank Ruschitzka
Nature Clinical Practice. Cardiovascular Medicine|September 28, 2005
Are selective cyclo-oxygenase 2 inhibitors safe after coronary artery bypass grafting surgery?Frank Ruschitzka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2006
Novel anti-inflammatory drugs in hypertensionMatthias Hermann, Frank Ruschitzka
International Journal of Clinical Practice|January 18, 2006
'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?Henry Krum, Frank Ruschitzka
Annals of Medicine|March 17, 2007
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugsMatthias Hermann, Frank Ruschitzka
Current Hypertension Reports|November 4, 2010
Is there a link between angiotensin receptor blockers and cancer?Frank Enseleit, Frank Ruschitzka
European Heart Journal|March 11, 2011
Beyond dyspnoea as an endpoint in acute heart failure trialsMihai Gheorghiade, Frank Ruschitzka
Current Hypertension Reports|March 28, 2008
Vitamin D and hypertensionMatthias Hermann, Frank Ruschitzka
Pageof 53